Pharma’s eastern promise

January 29, 2007
Sales and Marketing China, India

Thanks to spiralling costs, increasing regulation and the ever-present threat of litigious action, it is hardly surprising that pharma companies …

More than 250 UK jobs axed as Pfizer downsizes

January 26, 2007
Sales and Marketing

Pfizer's UK salesforce is likely to be in the front line following the company's decision to slash more than 250 …

Packer Forbes scoops GSK Tycerb account

January 26, 2007
Medical Communications GSK, Packer Forbest

London-based agency Packer Forbes Communications has won its first breast cancer account, to promote GlaxoSmithKline's potential blockbuster, Tycerb.The agency beat …

Patient experience survey is discredited says BMA

January 26, 2007

A row is brewing between doctors and the Department of Health over a major survey aimed at gauging patients' experiences …

Lucentis approved in Europe

January 26, 2007
Sales and Marketing Lucentis, Novartis

European regulators have approved Novartis’ Lucentis, a new treatment for neovascular age-related macular degeneration, known as wet AMD.The company says …

Januvia set for EU approval

January 26, 2007
Sales and Marketing

Januvia, the first in a new class of diabetes treatments, is set for approval in the European Union.Marketed by Merck …

Merck Serono picks Huntsworth for infertility work

January 26, 2007
Medical Communications Huntsworth

Newly merged biopharmaceutical company Merck Serono has awarded Huntsworth Health the UK account for one of biggest selling drugs.The agency …

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

New website to promote patient choice

January 24, 2007
patients

A new one-stop shop website is to be created to help NHS patients choose the best services for them.Plans to …

How happy are your workers?

January 22, 2007
Business Services HR, recruitment

Companies that get their working policies right not only tend to be more successful, they also make my job as …

NICE authority hangs in the balance ahead of court ruling

January 22, 2007

A High Court judge is poised to decide whether the first ever legal challenge to NICE guidance can go ahead …

Pfizer ponders over-the-counter Viagra

January 22, 2007
Sales and Marketing OTC

Viagra, the original erectile dysfunction wonder-drug could soon be available from pharmacies across Europe if its manufacturers apply for an …

Vectura buys Innovata

January 22, 2007
Research and Development biotech, vectura

 Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …

Novartis readies Prexige for osteoarthritis launch in Europe

January 22, 2007
Sales and Marketing prexige, safety

Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …

Work to begin on new NHS cancer strategy

January 22, 2007

 The government is to work with doctors, nurses, cancer charities and others to draw up a new Cancer Reform Strategy …

Wellcome Trust issues first grants to encourage drug discovery

January 19, 2007
Research and Development

The first awards have been made in the Wellcome Trust's £91 million, five-year plan for novel drugs to tackle obesity, …

AZ and Lilly set to follow Pfizer on supply chain

January 19, 2007
Manufacturing and Production counterfeits

Two major pharma companies could be set to follow Pfizer in using a single supply chain distributor of their medicines …

Minister’s promotion of statin switching proves controversial

January 19, 2007

The government says GPs could help save the health service £85 million a year by switching patients on branded statins …

Fast-track ‘not a soft option’ says NICE

January 19, 2007

The head of NICE's drug appraisal process has said the institute's new fast-track system is not a "soft option" through …

AZ and BMS combine to develop new diabetes drugs

January 19, 2007
Sales and Marketing

AstraZeneca and Bristol-Myers-Squibb are collaborating on the development of two new drugs for the treatment of type II diabetes.Saxagliptin, a …

The Gateway to Local Adoption Series

Latest content